These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 8662939)
1. Identification of a critical ligand binding determinant of the human erythropoietin receptor. Evidence for common ligand binding motifs in the cytokine receptor family. Middleton SA; Johnson DL; Jin R; McMahon FJ; Collins A; Tullai J; Gruninger RH; Jolliffe LK; Mulcahy LS J Biol Chem; 1996 Jun; 271(24):14045-54. PubMed ID: 8662939 [TBL] [Abstract][Full Text] [Related]
2. Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide. Middleton SA; Barbone FP; Johnson DL; Thurmond RL; You Y; McMahon FJ; Jin R; Livnah O; Tullai J; Farrell FX; Goldsmith MA; Wilson IA; Jolliffe LK J Biol Chem; 1999 May; 274(20):14163-9. PubMed ID: 10318834 [TBL] [Abstract][Full Text] [Related]
3. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Watowich SS; Hilton DJ; Lodish HF Mol Cell Biol; 1994 Jun; 14(6):3535-49. PubMed ID: 8196600 [TBL] [Abstract][Full Text] [Related]
4. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo. Miura O; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N Blood; 1994 Sep; 84(5):1501-7. PubMed ID: 8068943 [TBL] [Abstract][Full Text] [Related]
5. Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: implications for soluble receptor function. Schimmenti LA; Blechert G; Harris KW; Winkelmann JC Exp Hematol; 1995 Dec; 23(13):1341-6. PubMed ID: 7498361 [TBL] [Abstract][Full Text] [Related]
6. The extended box 2 subdomain of erythropoietin receptor is nonessential for Jak2 activation yet critical for efficient mitogenesis in FDC-ER cells. He TC; Jiang N; Zhuang H; Quelle DE; Wojchowski DM J Biol Chem; 1994 Jul; 269(28):18291-4. PubMed ID: 8034573 [TBL] [Abstract][Full Text] [Related]
7. Mutagenesis studies of the human erythropoietin receptor. Establishment of structure-function relationships. Barbone FP; Middleton SA; Johnson DL; McMahon FJ; Tullai J; Gruninger RH; Schilling AE; Jolliffe LK; Mulcahy LS J Biol Chem; 1997 Feb; 272(8):4985-92. PubMed ID: 9030560 [TBL] [Abstract][Full Text] [Related]
8. Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor. Hilton DJ; Watowich SS; Murray PJ; Lodish HF Proc Natl Acad Sci U S A; 1995 Jan; 92(1):190-4. PubMed ID: 7816815 [TBL] [Abstract][Full Text] [Related]
9. Saturation mutagenesis of the WSXWS motif of the erythropoietin receptor. Hilton DJ; Watowich SS; Katz L; Lodish HF J Biol Chem; 1996 Mar; 271(9):4699-708. PubMed ID: 8617735 [TBL] [Abstract][Full Text] [Related]
10. Physical and functional interaction between p72(syk) and erythropoietin receptor. Duprez V; Blank U; Chrétien S; Gisselbrecht S; Mayeux P J Biol Chem; 1998 Dec; 273(51):33985-90. PubMed ID: 9852052 [TBL] [Abstract][Full Text] [Related]
11. Mutations in the WSAWSE and cytosolic domains of the erythropoietin receptor affect signal transduction and ligand binding and internalization. Quelle DE; Quelle FW; Wojchowski DM Mol Cell Biol; 1992 Oct; 12(10):4553-61. PubMed ID: 1406645 [TBL] [Abstract][Full Text] [Related]
12. A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor. Hörtner M; Nielsch U; Mayr LM; Heinrich PC; Haan S Eur J Biochem; 2002 May; 269(10):2516-26. PubMed ID: 12027890 [TBL] [Abstract][Full Text] [Related]
13. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis. Tauchi T; Damen JE; Toyama K; Feng GS; Broxmeyer HE; Krystal G Blood; 1996 Jun; 87(11):4495-501. PubMed ID: 8639815 [TBL] [Abstract][Full Text] [Related]
14. Changes in conformation and stability upon formation of complexes of erythropoietin (EPO) and soluble EPO receptor. Narhi LO; Aoki KH; Philo JS; Arakawa T J Protein Chem; 1997 Apr; 16(3):213-25. PubMed ID: 9155092 [TBL] [Abstract][Full Text] [Related]
15. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain. Arcasoy MO; Karayal AF Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737 [TBL] [Abstract][Full Text] [Related]
16. Mutations in the Trp-Ser-X-Trp-Ser motif of the erythropoietin receptor abolish processing, ligand binding, and activation of the receptor. Yoshimura A; Zimmers T; Neumann D; Longmore G; Yoshimura Y; Lodish HF J Biol Chem; 1992 Jun; 267(16):11619-25. PubMed ID: 1317872 [TBL] [Abstract][Full Text] [Related]
17. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites. Yi T; Zhang J; Miura O; Ihle JN Blood; 1995 Jan; 85(1):87-95. PubMed ID: 7528577 [TBL] [Abstract][Full Text] [Related]
18. Erythropoietin receptor: application in drug development. Jolliffe LK; Middleton SA; Barbone FP; Johnson DL; McMahon FJ; Lee WH; Gruninger RH; Mulcahy LS Nephrol Dial Transplant; 1995; 10 Suppl 2():28-34. PubMed ID: 7644102 [TBL] [Abstract][Full Text] [Related]
19. Erythropoietin Receptor Structural Domains. Li Q; Kang C Vitam Horm; 2017; 105():1-17. PubMed ID: 28629512 [TBL] [Abstract][Full Text] [Related]